STOCK TITAN

RH SEC Filings

RH NYSE

Welcome to our dedicated page for RH SEC filings (Ticker: RH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

RH filings document a Delaware operating company with common stock listed on the New York Stock Exchange under the symbol RH. Recent 8-K reports furnish quarterly and annual operating results, shareholder letters and Regulation FD disclosure practices, while proxy materials cover board elections, executive compensation, auditor ratification and related shareholder votes.

The filing record also includes material-event disclosures for leadership changes and financing arrangements. Credit-agreement filings describe Restoration Hardware, Inc. as a wholly owned subsidiary and lead borrower, with borrowing capacity involving RH subsidiaries in Canada and Geneva, revolving credit commitments, maturity amendments and related lender arrangements.

Rhea-AI Summary

The Vanguard Group filed Amendment No. 11 to Schedule 13G/A reporting zero beneficial ownership in RH common stock after an internal realignment. The filing states that, effective January 12, 2026, certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538.

The filing lists 0 shares beneficially owned and 0% of the class, and is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
ownership
-
Rhea-AI Summary

RH director and officer Chaya Eri reported an option exercise and related share sales. Eri exercised 7,000 stock options at an exercise price of $39.42 per share, receiving 7,000 shares of common stock. On the same day, she sold 7,000 common shares in multiple open-market transactions at weighted average prices between roughly $127.96 and $130.74 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on October 7, 2024. Following these transactions, no direct common stock holdings are reported, while 23,643 shares are reported as held indirectly by the Chaya-Smith Revocable Trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

RH director and officer Chaya Eri exercised stock options for 7,000 shares of common stock at an exercise price of $39.4200 per share, then sold all 7,000 shares in open-market transactions on March 17, 2026.

The sales were executed in three tranches: 2,700 shares at a weighted average price of $134.5044, 3,292 shares at $135.7018, and 1,008 shares at $136.3972, under a Rule 10b5-1 trading plan adopted on October 7, 2024. After these transactions, Eri holds 43,000 stock options directly and 23,643 shares of common stock indirectly through the Chaya-Smith Revocable Trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

RH reported an insider equity vesting for senior executive Lisa Chi. On January 31, 2026, 6,000 restricted stock units (RSUs) vested and were converted into 6,000 shares of RH common stock at an exercise price of $0, all held directly.

These RSUs are part of a 20,000-unit award granted on May 30, 2025. The award vests over three years: 6,000 units vested on January 31, 2026, and 7,000 units are scheduled to vest on January 31, 2027 and January 31, 2028, subject to continuous service. After this transaction, Chi directly holds 14,000 RSUs and 6,000 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

RH announced that Stefan Duban, its Chief Gallery & Customer Officer, will depart the company as of January 26, 2026, under a mutual understanding consistent with his existing employment arrangements. His responsibilities have already been reassigned to other RH leaders, meaning the company has redistributed his duties across the current management team.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Trusts associated with RH director Mark S. Demilio reported sales of RH common stock. On January 13, 2026, The Mark S. Demilio Revocable Trust sold 2,000 RH shares at $220.1001 per share. On January 14, 2026, a trust reported as held "By Trust" sold an additional 2,254 shares at $220 per share.

After these transactions, one trust held 22,216 shares and then 19,962 shares following the later sale, another trust, The Theresa E. Demilio 2012 Family Trust, held 19,425 shares, and Mark S. Demilio also held 12,217 shares directly. The filing identifies Demilio as a director of RH and reports these positions as indirect or direct beneficial ownership through the respective trusts and personal holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

RH filed a notice of proposed sale under Rule 144 covering up to 2,254 shares of its common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE at an aggregate market value of 495880.00, with an approximate sale date of 01/14/2026. The filing notes 18777699 common shares outstanding.

The securities to be sold were acquired from the issuer through restricted stock vesting on 04/11/2024 and 06/29/2024, and through previously exercised options on 09/16/2025. The selling holder is identified as THE MARK S. DEMILIO REVOCABLE TRUST, which also sold 400, 500, and 2000 common shares in separate transactions over the prior three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

RH has a new Form 144 notice covering a planned sale of 2,000 shares of its common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 01/13/2026 and an aggregate market value of $440,200.20. The filing lists 18,777,699 common shares outstanding as context for the proposed sale.

The securities to be sold were acquired through restricted stock vesting under a registered plan, with 942 shares vesting on 04/11/2024, 547 shares on 06/27/2024, and 511 shares on 06/30/2023, all from the issuer and with no special payment terms described. The same trust account has sold RH common shares during the past three months, including 400 shares on 12/31/2025 for gross proceeds of $72,067.68 and 500 shares on 12/30/2025 for $92,000.00. By signing, the seller represents that they are not aware of undisclosed material adverse information about RH’s current or prospective operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

RH director Mark S. Demilio, through affiliated trusts, reported open-market sales of RH common stock. On 12/30/2025, a trust sold 500 shares at a price of $184 per share, and on 12/31/2025, a trust sold 400 shares at a weighted average price of $180.1692 per share. After these transactions, one trust held 24,116 shares, another trust held 19,425 shares, and Demilio also held 12,717 shares directly. The filing notes that the 12/31/2025 sale was executed in multiple trades within a specified price range, with detailed trade data available upon request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many RH (RH) SEC filings are available on StockTitan?

StockTitan tracks 71 SEC filings for RH (RH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for RH (RH)?

The most recent SEC filing for RH (RH) was filed on March 27, 2026.